Browsing Tag
Veterinary Biologics
2 posts
One shot, three months: Zoetis’ Lenivia earns EU nod for chronic dog pain relief
Zoetis receives EU approval for Lenivia, its first long-acting osteoarthritis antibody for dogs. Learn how this strengthens its leadership in veterinary biologics.
Zoetis (NYSE: ZTS) gains EMA panel endorsement for Lenivia — Could this reshape the €10bn companion-animal market?
Zoetis (NYSE: ZTS) earns EMA panel endorsement for Lenivia, a long-acting antibody injection for canine osteoarthritis pain. Find out what this means for investors and the veterinary industry.